SHILPA PHARMA LIFE SCIENCES

Shilpa Pharma Lifesciences, a subsidiary of Shilpa Medicare Limited, is a global pharmaceutical leader specializing in high-quality APIs and Finished Formulations. With expertise in oncology and non-oncology chemistry, the company provides end-to-end CDMO services—from research to commercial production—across USFDA, PMDA, and EUGMP-approved facilities.
Their portfolio features innovative dosage forms like injectables and transdermal patches, alongside a Bio division focused on advanced biologics and biosimilars. Committed to innovation and sustainability, Shilpa Pharma delivers affordable, life-saving therapies to over 50 countries, ensuring global access to cutting-edge healthcare solutions.